申请人:ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
公开号:US10730842B2
公开(公告)日:2020-08-04
This invention is in the field of medicinal chemistry. In particular, the invention relates to a new class of small-molecules having a benzimidazole or imidazopyridine structure which function as inhibitors of DYRK1A protein, and their use as therapeutics for the treatment of Alzheimer's disease, Down syndrome, glioblastoma, autoimmune diseases, inflammatory disorders (e.g., airway inflammation), and other diseases.
本发明属于药物化学领域。特别是,本发明涉及一类具有苯并咪唑或咪唑吡啶结构的新型小分子,它们可作为 DYRK1A 蛋白的抑制剂,并可用作治疗阿尔茨海默病、唐氏综合征、胶质母细胞瘤、自身免疫性疾病、炎症性疾病(如气道炎症)和其他疾病的疗法。